| GA23581-1mg |
|
1663490-91-2 |
|
0 |
C62H113N17O17 |
|
|
|
| GA23581-005mg |
|
1663490-91-2 |
|
0 |
C62H113N17O17 |
|
|
|
| GA23580-1mg |
|
330456-37-6 |
|
0 |
C72H125N23O19 |
|
|
|
| GA23580-005mg |
|
330456-37-6 |
|
0 |
C72H125N23O19 |
|
|
|
| GA23579-1mg |
|
2022995-68-0 |
Tau Peptide (255-314) (Repeat 2 Domain) (human)
|
0 |
C277H467N83O86S |
|
|
|
| GA23579-005mg |
|
2022995-68-0 |
Tau Peptide (255-314) (Repeat 2 Domain) (human)
|
0 |
C277H467N83O86S |
|
|
|
| GA23578-1mg |
|
1428134-39-7 |
Tau Peptide (245-274) (Repeat 1 Domain)
|
0 |
C136H230N40O42S |
|
|
|
| GA23578-005mg |
|
1428134-39-7 |
Tau Peptide (245-274) (Repeat 1 Domain)
|
0 |
C136H230N40O42S |
|
|
|
| GA23577-1mg |
|
330456-24-1 |
Tau Peptide (244-274) (Repeat 1 Domain)
|
0 |
C141H238N42O44S |
|
|
|
| GA23577-005mg |
|
330456-24-1 |
Tau Peptide (244-274) (Repeat 1 Domain)
|
0 |
C141H238N42O44S |
|
|
|
| GA23576-1mg |
|
2022956-53-0 |
Tau Peptide (1-16) (human)
|
0 |
C77H120N20O28S3 |
|
|
|
| GA23576-005mg |
|
2022956-53-0 |
Tau Peptide (1-16) (human)
|
0 |
C77H120N20O28S3 |
|
|
|
| GA23575-1mg |
|
118231-04-2 |
|
0 |
C99H151N35O19S4 |
|
|
|
| GA23575-005mg |
|
118231-04-2 |
|
0 |
C99H151N35O19S4 |
|
|
|
| GA23574-5mg |
|
104914-40-1 |
SV40 Nuclear Transport Signal Peptide Analog
|
0 |
C60H104N20O15S |
|
|
|
| GA23574-1mg |
|
104914-40-1 |
SV40 Nuclear Transport Signal Peptide Analog
|
0 |
C60H104N20O15S |
|
|
|
| GA23573-100mg |
|
185332-92-7 |
Sulfo-N-succinimidyl 4-maleimidobutyrate sodium salt
|
0 |
C12H11N2NaO9S |
|
|
|
| GA23573-50mg |
|
185332-92-7 |
Sulfo-N-succinimidyl 4-maleimidobutyrate sodium salt
|
0 |
C12H11N2NaO9S |
|
|
|
| GA23572-250mg |
|
95192-51-1 |
|
0 |
C30H37N3O6S |
|
|
|
| GA23572-50mg |
|
95192-51-1 |
|
0 |
C30H37N3O6S |
|
|
|
